Literature DB >> 19332548

Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cells.

Scott A Stuart1, Jean Y J Wang.   

Abstract

The cyclin-dependent kinase inhibitor p21(Cip1) plays an important role in the cellular response to DNA damage. In normal cells, genotoxic stress activates the ATM-p53 pathway that up-regulates the expression of p21(Cip1) leading to cell cycle arrest. However, we have found that in several neoplastic cell lines, ionizing radiation (IR) induces ubiquitin-dependent degradation of p21(Cip1). This process is independent of the ATM pathway as it occurs in immortalized A-T fibroblasts. Knockdown of Skp2, an F-box protein capable of regulating the normal turnover of p21(Cip1), does not prevent the IR-induced degradation. Instead, this process requires the Cul4-DDB1(Cdt2) E3 ligase as knockdown of either DDB1 or Cdt2 rescues p21(Cip1) degradation after IR. Mutating the proliferating cell nuclear antigen-binding site of p21(Cip1) also prevents its IR-induced degradation suggesting that the p21(Cip1)-proliferating cell nuclear antigen interaction is critical for this event. Although ectopic expression of a nondegradable p21(Cip1) did not by itself affect the clonogenic survival of HEK293 cells after IR, the degradation of p21(Cip1) and other targets of the Cul4-DDB1(Cdt2) E3 ligase may collectively contribute to the survival of neoplastic cells after ionizing radiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19332548      PMCID: PMC2685688          DOI: 10.1074/jbc.M808810200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

2.  Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.

Authors:  Y Gu; C W Turck; D O Morgan
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

3.  Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.

Authors:  A Noda; Y Ning; S F Venable; O M Pereira-Smith; J R Smith
Journal:  Exp Cell Res       Date:  1994-03       Impact factor: 3.905

4.  DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts.

Authors:  A Di Leonardo; S P Linke; K Clarkin; G M Wahl
Journal:  Genes Dev       Date:  1994-11-01       Impact factor: 11.361

5.  p21 is a universal inhibitor of cyclin kinases.

Authors:  Y Xiong; G J Hannon; H Zhang; D Casso; R Kobayashi; D Beach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

6.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

Authors:  M B Kastan; Q Zhan; W S el-Deiry; F Carrier; T Jacks; W V Walsh; B S Plunkett; B Vogelstein; A J Fornace
Journal:  Cell       Date:  1992-11-13       Impact factor: 41.582

7.  The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.

Authors:  S Waga; G J Hannon; D Beach; B Stillman
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

8.  p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

Authors:  V Dulić; W K Kaufmann; S J Wilson; T D Tlsty; E Lees; J W Harper; S J Elledge; S I Reed
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

9.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.

Authors:  J Chen; P K Jackson; M W Kirschner; A Dutta
Journal:  Nature       Date:  1995-03-23       Impact factor: 49.962

10.  The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.

Authors:  J W Harper; G R Adami; N Wei; K Keyomarsi; S J Elledge
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

View more
  16 in total

Review 1.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.

Authors:  Courtney G Havens; Johannes C Walter
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

2.  Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI.

Authors:  Gavin D Grant; Katarzyna M Kedziora; Juanita C Limas; Jeanette Gowen Cook; Jeremy E Purvis
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

3.  N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) triggers MSH2 and Cdt2 protein-dependent degradation of the cell cycle and mismatch repair (MMR) inhibitor protein p21Waf1/Cip1.

Authors:  Thomas Jascur; Rati Fotedar; Serena Greene; Erin Hotchkiss; C Richard Boland
Journal:  J Biol Chem       Date:  2011-07-02       Impact factor: 5.157

4.  Flipping the switch from g1 to s phase with e3 ubiquitin ligases.

Authors:  Lindsay F Rizzardi; Jeanette Gowen Cook
Journal:  Genes Cancer       Date:  2012-11

5.  Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications.

Authors:  Li-Ju Chang; Alan Eastman
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

6.  The ability of TRIM3 to induce growth arrest depends on RING-dependent E3 ligase activity.

Authors:  Radhika Raheja; Yuhui Liu; Ellen Hukkelhoven; Nancy Yeh; Andrew Koff
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

7.  TP53 gain-of-function mutation promotes inflammation in glioblastoma.

Authors:  Seok Won Ham; Hee-Young Jeon; Xiong Jin; Eun-Jung Kim; Jun-Kyum Kim; Yong Jae Shin; Yeri Lee; Se Hoon Kim; Seon Yong Lee; Sunyoung Seo; Min Gi Park; Hye-Mi Kim; Do-Hyun Nam; Hyunggee Kim
Journal:  Cell Death Differ       Date:  2018-05-21       Impact factor: 15.828

Review 8.  Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.

Authors:  Zhimin Lu; Tony Hunter
Journal:  Cell Cycle       Date:  2010-06-15       Impact factor: 4.534

Review 9.  p21 in cancer: intricate networks and multiple activities.

Authors:  Tarek Abbas; Anindya Dutta
Journal:  Nat Rev Cancer       Date:  2009-06       Impact factor: 60.716

10.  Jnk2 effects on tumor development, genetic instability and replicative stress in an oncogene-driven mouse mammary tumor model.

Authors:  Peila Chen; Jamye F O'Neal; Nancy D Ebelt; Michael A Cantrell; Shreya Mitra; Azadeh Nasrazadani; Tracy L Vandenbroek; Lynn E Heasley; Carla L Van Den Berg
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.